Entertainment Wire Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.

Press releases published on November 4, 2026

Nov. 4, 2026

Climb Bio to Present New Data for Budoprutug in Immune Thrombocytopenia at the 68th American Society of Hematology Annual Meeting and Exposition

Indeterminate GlobeNewswire

Nov. 4, 2026

Damora Therapeutics to Present New Preclinical Data Highlighting Potentially Best-in-Class Pan-Mutant Activity of DMR-001 in Mutant Calreticulin (mutCALR)-driven Myeloproliferative Neoplasms (MPN) at the American Society of Hematology (ASH) 2026 Annual…

Indeterminate GlobeNewswire

Nov. 4, 2026

Beam Therapeutics to Present Updated Clinical Data from BEACON Phase 1/2 Trial of Risto-cel in Sickle Cell Disease in an Oral Presentation at American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Secure Technology Alliance and Merchant Advisory Group Partner to Advance Trusted Agentic Commerce

Indeterminate GlobeNewswire

Nov. 4, 2026

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 4, 2026

Tango and Erasca Initiate Phase 1/2 Study of Oral PRMT5 Inhibitor Vopimetostat in Combination with Pan-RAS Molecular Glue ERAS-0015

Indeterminate GlobeNewswire

Nov. 4, 2026

At the Global Panda Partners 2026 Conference, Ya'an Shares Its Story of Harmonious Coexistence Between Humanity and Nature

Indeterminate GlobeNewswire

Nov. 4, 2026

"2026 Dialogue on Happy and Livable Cities & Business-Friendly Dialogue on Entrepreneurs' Sense of Happiness" held in Fuzhou, Fujian

Indeterminate GlobeNewswire

Nov. 4, 2026

Why the Next Edge in Antibody Discovery May Be What Labs Remember

Indeterminate GlobeNewswire

Nov. 4, 2026

With Long-Term Uranium at US$98, Wyoming’s In-Situ Basins Draw a New Acquirer

Indeterminate GlobeNewswire

Nov. 4, 2026

Liangshan, China: An Ecological Invitation Across Mountains and Seas

Indeterminate GlobeNewswire

Nov. 4, 2026

Intellia Therapeutics Completes Enrollment in Phase 3 MAGNITUDE-2 Trial of Nexiguran Ziclumeran (Nex-z) for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (ATTRv-PN)

Indeterminate GlobeNewswire

Nov. 4, 2026

The 9th Silk Road Dunhuang Expo Kicks Off for Cross‑Civilization Dialogue

Indeterminate GlobeNewswire

Nov. 4, 2026

Immuneering to Highlight Atebimetinib’s Broad Potential for Combinations in Pancreatic and Anaplastic Thyroid Cancers at the 2026 EORTC-NCI-AACR Symposium

Indeterminate GlobeNewswire

Nov. 4, 2026

Apostille FBI Report and Fingerprint Boston Join Forces on One-Stop FBI Background Check and Apostille Service

Indeterminate EIN Presswire

Nov. 4, 2026

uniQure Announces Third Quarter 2026 Financial Results and Provides Company Update

Indeterminate GlobeNewswire

Nov. 4, 2026

Sironax Announces Two Abstracts on NAMPT Activator SIR4156 Selected for Presentation at ObesityWeek 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Odyssey Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update 

Indeterminate GlobeNewswire

Nov. 4, 2026

Seres Therapeutics Reports Third Quarter 2026 Financial Results and Announces Plans for Advancing Development of SER-155 To Prevent Immune Checkpoint Inhibitor-Related Enterocolitis (irEC)

Indeterminate GlobeNewswire

Nov. 4, 2026

Rapport Therapeutics Reports Third Quarter 2026 Financials and Provides Business Update

Indeterminate GlobeNewswire